fluoxetine has been researched along with yohimbine in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.89) | 18.7374 |
| 1990's | 8 (21.05) | 18.2507 |
| 2000's | 13 (34.21) | 29.6817 |
| 2010's | 14 (36.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
| Benedetti, G; Del Bello, F; Diamanti, E; Giannella, M; Mammoli, V; Marchioro, C; Mattioli, L; Piergentili, A; Pigini, M; Quaglia, W; Titomanlio, F; Varrone, M | 1 |
| Hollander, E; McCarley, A | 1 |
| Jacobsen, FM | 1 |
| Garg, SK; Kulkarni, SK; Shukla, VK | 1 |
| Leander, JD; McCleary, PE | 1 |
| Mogilnicka, E | 1 |
| Bastide, P; Coudert, P; Rubat, C; Tronche, P | 1 |
| Segraves, RT | 1 |
| Terao, T | 1 |
| Balon, R | 1 |
| Delmeire, L; Maes, M; Meltzer, HY; Van Gastel, A | 1 |
| Chariot, J; Nagain-Domaine, C; Presset, O; Rozé, C | 1 |
| Abdali, SA; Kalsner, S | 1 |
| Ferris, CF; King, JA; Messenger, T | 1 |
| Berman, RM; Cappiello, A; Charney, DS; Fasula, D; Gueorguieva, R; Kugaya, A; Liu, N; Oren, DA; Sanacora, G | 1 |
| Cuadra, GR; Orsingher, OA; Ramírez, OA; Sodero, AO; Valdomero, A | 1 |
| Love, JA; Yi, E | 1 |
| Gueorguieva, RV; Sanacora, G | 1 |
| Barrera, G; Drolet, G; Hernandez, A; Laforest, S; Morilak, DA; Poulin, JF | 1 |
| Hogg, S; Jessa, M; Michan, L | 1 |
| Dhir, A; Kulkarni, SK | 2 |
| Eid, NM; George, RF; Hanna, MM; Safwat, HM | 1 |
| Rosenzweig-Lipson, S; Schechter, LE; Sukoff Rizzo, SJ | 1 |
| Brocardo, PS; Budni, J; Kaster, MP; Rodrigues, AL; Santos, AR | 1 |
| Cui, CC; Feng, J; Xu, HL; Yi, LT; Zhan, X; Zhou, LP | 1 |
| Costentin, J; Do Rego, JC; Müller, LG; Nunes, JM; Rates, SM; Stein, AC; Stolz, ED; Viana, AF; von Poser, GL | 1 |
| Amaral, VC; Campos, KF; Miguel, TT; Nunes-de-Souza, RL; Rico, JL | 1 |
| Ali, AS; Ali, SA; Salim, S | 1 |
| Mendes-Gomes, J; Nunes-de-Souza, RL; Rico, JL; Rodgers, RJ; Sorregotti, T | 1 |
| Fernández-Guasti, A; Ventura-Aquino, E | 1 |
| Fitzgerald, PJ; Maren, S; Seemann, JR | 1 |
| Abbas, G; Bhatti, HA; Mahmood, W; Rauf, K; Zada, W; Zeeshan, S | 1 |
| Berquist, MD; Mooney-Leber, SM; Pehrson, AL; Porter, JH; Porter, NP; Prus, AJ | 1 |
| Alberton, MD; Barauna, SC; de Albuquerque, CAC; Mello, J; Micke, GA; Pauleti, NN; Siebert, DA | 1 |
1 review(s) available for fluoxetine and yohimbine
| Article | Year |
|---|---|
Can fear extinction be enhanced? A review of pharmacological and behavioral findings.
Topics: Animals; Conditioning, Classical; Extinction, Psychological; Fear; Fluoxetine; Humans; Levodopa; Neurotransmitter Agents; Propranolol; Yohimbine | 2014 |
3 trial(s) available for fluoxetine and yohimbine
| Article | Year |
|---|---|
Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers.
Topics: Adult; Clomipramine; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Serotonin; Sexual Dysfunctions, Psychological; Yohimbine | 1992 |
Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.
Topics: Adult; Depressive Disorder; Erectile Dysfunction; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Orgasm; Penile Erection; Sexual Dysfunctions, Psychological; Yohimbine | 1992 |
Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; Treatment Outcome; Yohimbine | 2004 |
34 other study(ies) available for fluoxetine and yohimbine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Low Doses of Allyphenyline and Cyclomethyline, Effective against Morphine Dependence, Elicit an Antidepressant-like Effect.
Topics: | 2012 |
Modification by clonidine of harmine-induced tremors in mice: involvement of serotoninergic system.
Topics: Alkaloids; Animals; Clonidine; Cyproheptadine; Fluoxetine; Harmine; Male; Mice; Quipazine; Serotonin; Tremor; Yohimbine | 1986 |
Clonidine analgesia and suppression of operant responding: dissociation of mechanism.
Topics: Analgesics; Animals; Clonidine; Conditioning, Operant; Drug Interactions; Fluoxetine; Male; Norepinephrine; Phenoxybenzamine; Rats; Xylazine; Yohimbine | 1981 |
The effects of acute and repeated treatment with salbutamol, a beta-adrenoceptor agonist, on clonidine-induced hypoactivity in rats.
Topics: Albuterol; Animals; Clonidine; Desipramine; Drug Interactions; Exploratory Behavior; Fluoxetine; Imipramine; Male; Propranolol; Rats; Rats, Inbred Strains; Yohimbine | 1982 |
Behavioural profile of two potential antidepressant pyridazine derivatives including arylpiperazinyl moieties in their structure, in mice.
Topics: 5-Hydroxytryptophan; Analgesia; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Blepharoptosis; Citalopram; Clomipramine; Drug Interactions; Fluoxetine; Hypothermia; Imipramine; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Models, Molecular; Motor Activity; Naloxone; Piperazines; Pyridazines; Reserpine; Structure-Activity Relationship; Swimming; Trazodone; Yohimbine | 1995 |
Treatment of drug-induced anorgasmia.
Topics: Female; Fluoxetine; Humans; Male; Orgasm; Paroxetine; Sexual Dysfunctions, Psychological; Yohimbine | 1994 |
Titration of serotonin reuptake blockers.
Topics: Amantadine; Drug Administration Schedule; Fluoxetine; Humans; Mental Disorders; Recurrence; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Yohimbine | 1993 |
Fluoxetine-induced sexual dysfunction and yohimbine.
Topics: Drug Therapy, Combination; Fluoxetine; Humans; Male; Penile Erection; Priapism; Sexual Dysfunctions, Psychological; Trazodone; Yohimbine | 1993 |
Decreased platelet alpha-2 adrenoceptor density in major depression: effects of tricyclic antidepressants and fluoxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; Case-Control Studies; Depressive Disorder; Down-Regulation; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Middle Aged; Receptors, Adrenergic, alpha-2; Statistics as Topic; Treatment Outcome; Up-Regulation; Yohimbine | 1999 |
Modulation of external pancreatic secretion by endogenous norepinephrine: study with a norepinephrine uptake blocker in the rat.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Deoxyglucose; Electric Stimulation; Fluoxetine; Idazoxan; Kinetics; Male; Norepinephrine; Pancreas; Prazosin; Propranolol; Rats; Rats, Wistar; Vagus Nerve; Yohimbine | 1999 |
Rate-independent inhibition by norepinephrine of 5-HT release from the somadendritic region of serotonergic neurons.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Dendrites; Dose-Response Relationship, Drug; Electric Stimulation; Feedback; Fluoxetine; Mesencephalon; Methiothepin; Neural Inhibition; Neurons; Norepinephrine; Phenylephrine; Prazosin; Rabbits; Raphe Nuclei; Receptors, Adrenergic; Serotonin; Serotonin Antagonists; Yohimbine | 2001 |
Seed finding in golden hamsters: a potential animal model for screening anxiolytic drugs.
Topics: Adrenergic alpha-Agonists; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Appetitive Behavior; Behavior, Animal; Buspirone; Chlordiazepoxide; Clozapine; Cricetinae; Desipramine; Drug Evaluation, Preclinical; Fasting; Fluoxetine; Injections, Intraperitoneal; Male; Mesocricetus; Models, Animal; Stress, Psychological; Yohimbine | 2002 |
Locus coeruleus activity in perinatally protein-deprived rats: effects of fluoxetine administration.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amphetamines; Animals; Antidepressive Agents, Second-Generation; Biogenic Monoamines; Clonidine; Dose-Response Relationship, Drug; Electrophysiology; Extracellular Space; Female; Fluoxetine; Locus Coeruleus; Microdialysis; Neurons; Norepinephrine; Prefrontal Cortex; Pregnancy; Protein-Energy Malnutrition; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Yohimbine | 2004 |
Alpha-adrenergic modulation of synaptic transmission in rabbit pancreatic ganglia.
Topics: Adrenergic alpha-Agonists; Animals; Clonidine; Excitatory Postsynaptic Potentials; Female; Fluoxetine; Ganglia, Autonomic; Guanethidine; Male; Neural Inhibition; Norepinephrine; Pancreas; Phenylephrine; Rabbits; Receptors, Adrenergic; Synaptic Transmission; Yohimbine | 2005 |
Joint analysis of repeatedly observed continuous and ordinal measures of disease severity.
Topics: Biometry; Clinical Trials as Topic; Computer Simulation; Data Interpretation, Statistical; Depression; Fluoxetine; Humans; Likelihood Functions; Longitudinal Studies; Psychiatric Status Rating Scales; Regression Analysis; Severity of Illness Index; Software; Yohimbine | 2006 |
Galanin-mediated anxiolytic effect in rat central amygdala is not a result of corelease from noradrenergic terminals.
Topics: Adrenergic Agents; Adrenergic alpha-Antagonists; Amygdala; Animals; Anti-Anxiety Agents; Autoradiography; Behavior, Animal; Cell Count; Cholera Toxin; Drug Interactions; Fluoxetine; Galanin; Gene Expression Regulation; Immunohistochemistry; In Situ Hybridization; Locus Coeruleus; Male; Maze Learning; Norepinephrine; Oncogene Proteins v-fos; Oxidopamine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Restraint, Physical; Septal Nuclei; Stilbamidines; Stress, Physiological; Tritium; Yohimbine | 2006 |
Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.
Topics: Adrenergic alpha-Antagonists; Alprazolam; Animals; Anxiety; Citalopram; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Hypnotics and Sedatives; Male; Motor Activity; Panic Disorder; Paroxetine; Periaqueductal Gray; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stereotaxic Techniques; Yohimbine | 2006 |
Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Fluoxetine; Male; Mice; Motor Activity; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; Venlafaxine Hydrochloride; Yohimbine | 2007 |
Synthesis of some tropane derivatives of anticipated activity on the reuptake of norepinephrine and/or serotonin.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-Antagonists; Animals; Citalopram; Clomipramine; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Mice; Molecular Structure; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tropanes; Yohimbine | 2007 |
A novel approach for predicting antidepressant-induced sexual dysfunction in rats.
Topics: Animals; Antidepressive Agents; Bupropion; Desipramine; Disease Models, Animal; Dopamine Agonists; Fluoxetine; Long-Term Care; Male; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Vasodilator Agents; Yohimbine | 2008 |
Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Depression; Female; Fenclonine; Fluoxetine; Folic Acid; Hindlimb Suspension; Injections, Intraventricular; Male; Mice; Motor Activity; Norepinephrine; Prazosin; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Swimming; Yohimbine | 2008 |
Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Immobility Response, Tonic; Locomotion; Male; Mice; Receptors, Adrenergic, alpha-2; Risperidone; Swimming; Venlafaxine Hydrochloride; Yohimbine | 2008 |
Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin.
Topics: Adrenergic Antagonists; Animals; Antidepressive Agents; Benzazepines; Cyproheptadine; Depression; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Flavones; Fluoxetine; Hindlimb Suspension; Male; Mice; Mice, Inbred ICR; Motor Activity; Piperazines; Prazosin; Propranolol; Pyridines; Serotonin Antagonists; Sulpiride; Swimming; Yohimbine | 2011 |
Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs.
Topics: Animals; Antidepressive Agents; Benzazepines; Biogenic Monoamines; Bupropion; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fenclonine; Fluoxetine; Hypericum; Imipramine; Immobility Response, Tonic; Locomotion; Male; Mice; Mice, Inbred Strains; Phloroglucinol; Plant Extracts; Prazosin; Rats; Rats, Wistar; Receptors, Catecholamine; Sulpiride; Vesicular Monoamine Transport Proteins; Yohimbine | 2012 |
Ethopharmacological evaluation of the rat exposure test: a prey-predator interaction test.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Caffeine; Central Nervous System Stimulants; Diazepam; Escape Reaction; Factor Analysis, Statistical; Fluoxetine; Food Chain; Imipramine; Male; Mice; Motor Activity; Posture; Predatory Behavior; Rats; Rats, Long-Evans; Time Factors; Yohimbine | 2013 |
5-HT receptor subtypes as key targets in mediating pigment dispersion within melanophores of teleost, Oreochromis mossambicus.
Topics: Allylbenzene Derivatives; Animals; Benzyl Compounds; Dioxolanes; Dose-Response Relationship, Drug; Fish Proteins; Fluoxetine; Melanins; Melanophores; Metergoline; Pigments, Biological; Pyrogallol; Receptors, Serotonin; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Sumatriptan; Tilapia; Trazodone; Yohimbine | 2013 |
Ethopharmacological analysis of the open elevated plus-maze in mice.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Convulsants; Corticosterone; Diazepam; Factor Analysis, Statistical; Fluoxetine; Male; Maze Learning; Mice; Pentylenetetrazole; Statistics, Nonparametric; Yohimbine | 2013 |
The antidepressants fluoxetine and bupropion differentially affect proceptive behavior in the naturally cycling female rat.
Topics: Animals; Antidepressive Agents; Bupropion; Estrous Cycle; Female; Fluoxetine; Humans; Male; Rats; Selective Serotonin Reuptake Inhibitors; Sex Factors; Sexual Behavior, Animal; Yohimbine | 2013 |
Cinnamomum cassia: an implication of serotonin reuptake inhibition in animal models of depression.
Topics: Animals; Antidepressive Agents; Cinnamomum aromaticum; Depression; Disease Models, Animal; Fluoxetine; Hindlimb Suspension; Male; Mice, Inbred BALB C; Motor Activity; Plant Bark; Plant Extracts; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; Yohimbine | 2016 |
The antidepressant drugs fluoxetine and duloxetine produce anxiolytic-like effects in a schedule-induced polydipsia paradigm in rats: enhancement of fluoxetine's effects by the α2 adrenoceptor antagonist yohimbine.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Anti-Anxiety Agents; Antidepressive Agents; Disease Models, Animal; Drinking; Drinking Water; Duloxetine Hydrochloride; Fluoxetine; Food Deprivation; Male; Polydipsia; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Yohimbine | 2015 |
Characterisation of phenolic compounds of the ethyl acetate fraction from Tabernaemontana catharinensis and its potential antidepressant-like effect.
Topics: Acetates; Animals; Antidepressive Agents; Coumaric Acids; Depression; Fluoxetine; Mice; Phenols; Plant Extracts; Propionates; Tabernaemontana; Yohimbine | 2018 |